Discovery of Potent NS5A Inhibitors with Favorable Pharmacokinetics and Robust Activity in an HCV Animal Model

Conference Reports for NATAP

5th International Workshop on Hepatitis C
Resistance and New Compounds
24-25 June 2010, Boston, MA USA


Discovery of Potent NS5A Inhibitors with Favorable Pharmacokinetics and Robust Activity in an HCV Animal Model

	B. Buckman, Intermune Reported by Jules Levin The 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 23-24, 2010